阻塞性睡眠呼吸暂停对COPD患者的功能表现和肌肉质量的影响
Patrícia Faria Camargo1, Guilherme Dionir Back1, Luiz Carlos Soares de Carvalho-Junior2
1Physiotherapy Department, Cardiopulmonary Physiotherapy Laboratory, Federal University of Sao Carlos, Sao Carlos, Sao Paulo, Brazil.
Scientific reports
|December 16, 2025
概括
患有慢性阻塞性肺病和阻塞性睡眠呼吸暂停 (COPD-OSAS) 的人体验到更差的肌肉质量和身体功能. 通过氧气脱度指数 (ODI) 表示的夜间缺氧显著影响了这些结果.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 睡眠医学 睡眠医学
- 老年学是指老年学的学科.
背景情况:
- 慢性阻塞性肺病 (COPD) 经常与阻塞性睡眠呼吸暂停 (OSAS) 共同存在.
- 这两种情况独立地影响肌肉质量和功能能力.
- 慢性肺炎和OSAS对这些参数的综合影响需要进一步调查.
研究的目的:
- 调查夜间氧气脱,肌肉质量和COPD患者的功能表现与没有OSAS患者之间的关联.
- 在这个患者群体中确定肌肉质量的预测因素.
主要方法:
- 一组44名参与者 (22名COPD,22名COPD-OSAS) 接受了为期3天的评估.
- 评估包括肺功能,身体组成,心脏功能,家庭睡眠监测 (AHI,ODI),手握强度 (HGS) 和6分钟步行测试 (6MWT).
- 肌肉质量被定义为附骨肌肉质量相对于同度强度.
主要成果:
- 与仅患有COPD的患者相比,COPD-OSAS患者的6MWT距离和HGS显著降低.
- 睡眠障碍呼吸指数 (AHI,ODI) 与功能表现和肌肉质量相反相关.
- 多变量回归确定了性别,AHI和ODI作为肌肉质量的独立预测因素,ODI是最强的.
结论:
- COPD-OSAS与肌肉质量和体力表现的较大损害有关.
- 夜间低氧负担,特别是ODI,是COPD患者肌肉质量降低的重要因素.
- 需要对更大规模的纵向研究进行进一步的研究,以了解机制和临床影响.
相关概念视频
Sleep Apnea
449
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
449
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
COPD: Management Using Bronchodilators and Corticosteroids
700
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
700
Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K


